Schizophrenia looking at the relationship of smoking prevalence with clinical symptoms and medication induced symptoms

According to the World Health Organization (WHO), the impact of schizophrenia has been found to be the highest among Southeast Asian countries with Singapore ranking seven globally in terms of disability-adjusted life year (DALY) scores (a measure of overall disease burden). More worryingly, schizop...

Full description

Saved in:
Bibliographic Details
Main Author: Neo, Shee Ling
Other Authors: Douglas B. Matthews
Format: Final Year Project
Language:English
Published: 2013
Subjects:
Online Access:http://hdl.handle.net/10356/52507
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-52507
record_format dspace
spelling sg-ntu-dr.10356-525072019-12-10T11:29:15Z Schizophrenia looking at the relationship of smoking prevalence with clinical symptoms and medication induced symptoms Neo, Shee Ling Douglas B. Matthews School of Humanities and Social Sciences DRNTU::Social sciences According to the World Health Organization (WHO), the impact of schizophrenia has been found to be the highest among Southeast Asian countries with Singapore ranking seven globally in terms of disability-adjusted life year (DALY) scores (a measure of overall disease burden). More worryingly, schizophrenia is one of the mental illnesses with the highest prevalence rate of smoking. It was reported that the rate of smoking in the schizophrenic population is two to four times that of the general population. This puts forth the possibility that smoking and schizophrenia may share a common underlying physiology. It has also been suggested in multiple literature that smoking behaviors among schizophrenics may be an attempt to treat an underlying biological pathology by self-administration of nicotine. This paper aims to further current understanding of schizophrenia by examining the potential implications of the radical prevalence of smoking in schizophrenic patients. In this paper, an overview of the explanations for high rate of smoking in schizophrenia in terms of clinical reports of sensory, sensori-motor and cognitive deficits of schizophrenia, the undesirable side effects of the use of antipsychotics and the role of nicotine in modulating these symptoms and deficits is presented as major support for the self-medication hypothesis. Bachelor of Arts 2013-05-15T03:04:20Z 2013-05-15T03:04:20Z 2013 2013 Final Year Project (FYP) http://hdl.handle.net/10356/52507 en Nanyang Technological University 81 p. application/pdf
institution Nanyang Technological University
building NTU Library
country Singapore
collection DR-NTU
language English
topic DRNTU::Social sciences
spellingShingle DRNTU::Social sciences
Neo, Shee Ling
Schizophrenia looking at the relationship of smoking prevalence with clinical symptoms and medication induced symptoms
description According to the World Health Organization (WHO), the impact of schizophrenia has been found to be the highest among Southeast Asian countries with Singapore ranking seven globally in terms of disability-adjusted life year (DALY) scores (a measure of overall disease burden). More worryingly, schizophrenia is one of the mental illnesses with the highest prevalence rate of smoking. It was reported that the rate of smoking in the schizophrenic population is two to four times that of the general population. This puts forth the possibility that smoking and schizophrenia may share a common underlying physiology. It has also been suggested in multiple literature that smoking behaviors among schizophrenics may be an attempt to treat an underlying biological pathology by self-administration of nicotine. This paper aims to further current understanding of schizophrenia by examining the potential implications of the radical prevalence of smoking in schizophrenic patients. In this paper, an overview of the explanations for high rate of smoking in schizophrenia in terms of clinical reports of sensory, sensori-motor and cognitive deficits of schizophrenia, the undesirable side effects of the use of antipsychotics and the role of nicotine in modulating these symptoms and deficits is presented as major support for the self-medication hypothesis.
author2 Douglas B. Matthews
author_facet Douglas B. Matthews
Neo, Shee Ling
format Final Year Project
author Neo, Shee Ling
author_sort Neo, Shee Ling
title Schizophrenia looking at the relationship of smoking prevalence with clinical symptoms and medication induced symptoms
title_short Schizophrenia looking at the relationship of smoking prevalence with clinical symptoms and medication induced symptoms
title_full Schizophrenia looking at the relationship of smoking prevalence with clinical symptoms and medication induced symptoms
title_fullStr Schizophrenia looking at the relationship of smoking prevalence with clinical symptoms and medication induced symptoms
title_full_unstemmed Schizophrenia looking at the relationship of smoking prevalence with clinical symptoms and medication induced symptoms
title_sort schizophrenia looking at the relationship of smoking prevalence with clinical symptoms and medication induced symptoms
publishDate 2013
url http://hdl.handle.net/10356/52507
_version_ 1681038698124148736